Dendreon's Provenge becomes first therapeutic cancer vaccine to be approved in US

The first therapeutic cancer vaccine has been approved in the US by the FDA, Dendreon's Provenge (sipuleucel-T). The long-awaited development will boost the field of cancer immunotherapy, a novel approach that stimulates the immune system to fight the disease.